Comprehensive Oncology: Pathophysiology, Diagnosis, and Nursing Management

Stages of Cancer Development

  • The development of cancer is a multi-stage process involving three specific phases:
        - Initiation: The first stage where the cellular DNA is damaged or mutated.
        - Promotion: The second stage where cells begin to divide and multiply rapidly.
        - Progression: The third stage characterized by the spread or metastasis of cancer cells throughout the body.

Etiology and Risk Factors of Cancer

  • The causes of cancer are multifactorial, arising from a complex interplay of various triggers rather than a single source.
  • Genetic Factors:
        - Family history is a critical component.
        - Having first-degree relatives with cancer is a significant risk factor.
        - Recognition of this history should lead to earlier or more frequent screenings.
  • Environmental Exposures:
        - Exposure to chemicals can damage DNA, specifically benzene and formaldehyde.
        - Radiation is a known contributor to increased cancer risk through DNA damage.
  • Viral Pathogens:
        - Human Immunodeficiency Virus (HIV).
        - Human Papillomavirus (HPV).
        - TBAR virus (associated with increased risks).
  • Dietary Factors:
        - High intake of fatty foods.
        - Consumption of red beets (associated with increased risk in this context).
  • Lifestyle Factors:
        - Sedentary lifestyle (lack of movement).
        - Obesity (BMI management is crucial).
        - Unsafe sexual practices.

Classification and Staging of Cancer

  • Tumor Classification:
        - Benign: Generally non-invasive.
        - Malignant: The major distinction is the ability of malignant tumor cells to invade surrounding tissues and metastasize to distant sites.
  • Staging Systems:
        - Cancer staging classifies tumors based on anatomical location, cellular characteristics, and the extent of spread.
        - Staging is essential for guiding treatment decisions and predicting prognosis and survival.
        - TNM System: Historically the most common staging method, assessing Tumor, Nodes, and Metastasis.
  • Clinical Staging Classifications:
        - Stage 00: Cancer in situ (indicates cancer has not spread from its original space of development).
        - Stage 11: Tumor is limited to its tissue of origin.
        - Stage 22: Indicates limited local spread.
        - Stage 33: Indicates extensive local and regional spread.
        - Stage 44: Signifies distant metastasis (spread to other parts of the body).

Clinical Manifestations and Diagnosis

  • General Manifestations:
        - Unexplained weight loss.
        - Fatigue.
        - Palpable masses or lumps.
        - Swelling.
        - Pain.
        - Changes in skin appearance.
  • Diagnostic Planning:
        - Begins with a thorough health history, including the history of present illness and identification of risk factors.
  • Biopsies:
        - Biopsies are necessary to make a conclusive cancer diagnosis.
        - A pathologist performs a histological examination of removed tissue to determine the presence and type of cancer.
        - Methods include needle aspiration, fine-needle aspiration, or incisional procedures where part of a lesion is removed.
  • Radiographic and Imaging Studies:
        - X-rays, CAT scans, and MRIs are used to visualize internal structures and determine tumor size, location, and spread.
        - Radioisotope Scans (Nuclear Medicine): Involves injecting or ingesting a small amount of radioactive material detected by a gamma camera to highlight abnormal tissue activity.
        - PET Scan (Positron Emission Tomography): A functional imaging test where cancer cells absorb sugar, appearing on the scan to allow detection of tumor activity and metastasis.
  • Tumor Markers:
        - Substances (usually proteins) produced by cancer cells or the body in response to cancer.
        - Measured through blood, urine, or tissue tests.
        - Identified through molecular techniques to help identify inherited risk, guide prognosis, and inform targeted therapy.

Prevention and Health Promotion

  • Avoidance of Carcinogens:
        - Avoid cigarette smoking and secondhand smoke.
        - Minimize sun exposure.
        - Utilize smoking cessation programs under medical guidance.
  • Alcohol Moderation:
        - Women should limit intake to 11 drink per day.
        - Men should limit intake to 22 drinks per day.
  • Activity and Weight:
        - Regular exercise (30 minutes30\,\text{minutes} of moderate exercise as tolerated).
        - Healthy weight maintenance through BMI management in diet and activity.
  • General Wellness:
        - Adequate rest/quality sleep for immune function and mental health.
        - Stress management and coping strategies.
        - Routine health screenings and awareness of family history.

Goals and Modalities of Cancer Treatment

  • Treatment usually involves a multimodal approach (Surgery, Chemotherapy, Radiation).
  • Primary Goals:
        - Cure: Eradicating all cancer cells to achieve remission.
        - Control: Managing disease progression and prolonging survival.
        - Palliation: Relieving symptoms and improving quality of life when cure or control are not feasible.
  • Individualization: Treatment plans are tailored based on cancer type, stage, patient health status, and personal preferences.

Surgical Therapy

  • Often the first-line treatment for solid tumors.
  • Objectives:
        - Curative Intent: Removal of the entire localized tumor.
        - Debulking: Removing as much of the tumor mass as possible to improve the efficacy of chemotherapy or radiation.
        - Palliative Measures: Relieving symptoms like obstruction, bleeding, or pain in advanced cases.
  • Decision Factors: Stage, anatomical location, patient comorbidities, and impact on organ function/quality of life.
  • Modern Trends: A shift toward less radical surgeries to preserve normal tissue and function while achieving effective removal.

Chemotherapy (Antineoplastic Therapy)

  • Uses chemical agents as a systemic treatment targeting cancer cells throughout the body.
  • Mainstay for solid tumors and hematologic cancers (leukemias, lymphomas).
  • Common Side Effects and Nursing Management:
        - Fatigue: Caused by cell damage and anemia. Nurses should encourage rest, balanced nutrition, and light exercise.
        - Nausea and Vomiting: Administer anti-Vmeds (anti-emetics) before treatment. Educate on eating small frequent meals, room temperature/chilled foods, and avoiding heavy meals before chemo.
        - Diarrhea: Results from intestinal lining damage. Management involves low roughage/high fiber fluids and antidiarrheal medications.
        - Hair Loss (Alopecia): Caused by follicle damage. Provide emotional support and discuss options like wigs, scarves, or hats.
        - Mucositis: Painful sores in the mouth/GI tract. Use saline rinses; avoid alcohol-based products. "Magic mouthwash" may be prescribed.
        - Myelosuppression: Suppression of bone marrow leading to anemia, leukopenia, and thrombocytopenia. Requires regular blood count monitoring.
        - Cognitive Changes ("Chemo Brain"): Impaired memory and concentration. Encourage mental exercises (crossword puzzles) and memory aids.
        - Weight Loss/Nutrition: Combat decreased appetite and taste changes by adding healthy oils, butter, nut butters, avocados, and replacing water with milk or high-calorie liquids.

Immunotherapy

  • Helps the immune system recognize and attack cancer cells.
  • Types: CAR T-cell therapy, cytokines, monoclonal antibodies, and cancer vaccines.
  • Side Effects: Flu-like symptoms (fever, chills, body aches, runny nose), fatigue, GI issues, and photosensitivity.
  • Nursing Management:
        - Monitor vitals, especially temperature.
        - Administer antipyretics and provide comfort (warm blankets).
        - Safety: Nurses must wear full Personal Protective Equipment (PPE) when preparing or administering these biologically active/hazardous drugs to avoid skin contact or inhalation.

Radiation Therapy

  • External Beam Radiation:
        - High-energy radiation delivered to a defined area.
        - The patient is not radioactive; visitors are safe.
        - Skin Care: Gently cleanse with mild soap/warm water; pat dry. Avoid perfumes, harsh soaps, tight clothing, scratching, and direct heat (no heating pads/patches). Do not wash off the radiologist's markings.
  • Internal Radiation (Brachytherapy):
        - Sealed radiation sources implanted near/in the tumor.
        - The patient emits radiation.
        - Safety Precautions: Limited visitation; avoid contact with pregnant individuals and children. Nurses utilize shielding, film badges to monitor cumulative exposure, and organize care to minimize time spent near the patient.

Stem Cell Transplantation

  • Goal: Destroy tumor cells using high-dose chemotherapy/radiation and replace damaged bone marrow with healthy stem cells.
  • Types of Grafts:
        - Autologous: Self-donor.
        - Allogeneic: From a donor.
  • Complications: Graft-versus-host disease (GVHD) where donor cells attack the patient.
        - Symptoms: Rash/peeling (skin), jaundice/elevated enzymes (liver), bloody diarrhea (GI).
        - Timing: Acute (100100 days or less post-transplant) or Chronic (after 100100 days).
  • Recovery and Safety:
        - Pancytopenia is common; it takes 22 to 44 weeks for new blood production.
        - Infection Prevention: Hand hygiene, avoiding crowds, wearing masks, and avoiding raw foods or fresh flowers.
        - Bleeding Precautions: Use soft toothbrushes and monitor for bruising.

Nursing Roles and Survivorship

  • Educate patients on discussing individualized screening plans based on family history.
  • Advise patients never to stop medications suddenly and to consult doctors for all concerns.
  • Provide specific education on managing side effects at home (e.g., crushing medicine into ice cream if necessary for comfort/intake).
  • Survivorship: There are currently more than 14.5 million14.5\,\text{million} cancer survivors in the United States.
  • Long-term Monitoring: Providers must monitor for secondary cancers, cardiovascular issues, sexual dysfunction, and late cognitive changes.